Prior treatment with dipeptidyl peptidase 4 inhibitors is associated with better functional outcome and lower in-hospital mortality in patients with type 2 diabetes mellitus admitted with acute ischaemic stroke

In conclusion, prior treatment with dipeptidyl peptidase 4 inhibitors in patients with acute ischaemic stroke appears to be associated with better functional outcome and lower mortality risk.

Source: Diabetes and Vascular Disease Research - October 22, 2015 Category: Endocrinology Authors: Tziomalos, K., Bouziana, S. D., Spanou, M., Kostaki, S., Papadopoulou, M., Giampatzis, V., Dourliou, V., Kostourou, D.-T., Savopoulos, C., Hatzitolios, A. I. Tags: Brief Reports Source Type: research